(Q35149622)

6 August 2017

title

Pilot study of p62 DNA vaccine in dogs with mammary tumors (English)

1 reference

6 August 2017

Vladimir Gabai

1

1 reference

6 August 2017

Franco M Venanzi

2

1 reference

6 August 2017

Elena Bagashova

3

1 reference

6 August 2017

Oksana Rud

4

1 reference

6 August 2017

Francesca Mariotti

5

1 reference

6 August 2017

Cecilia Vullo

6

1 reference

6 August 2017

Giuseppe Catone

7

1 reference

6 August 2017

Michael Y Sherman

8

1 reference

6 August 2017

Antonio Concetti

9

1 reference

6 August 2017

Andrey Chursov

10

1 reference

6 August 2017

Anastasia Latanova

11

1 reference

6 August 2017

Vita Shcherbinina

12

1 reference

6 August 2017

Victor Shifrin

13

1 reference

6 August 2017

Alexander Shneider

14

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 December 2014

1 reference

6 August 2017

1 reference

6 August 2017

volume

5

1 reference

6 August 2017

issue

24

1 reference

6 August 2017

page(s)

12803-12810

1 reference

Feasibility analysis of p62 (SQSTM1)-encoding DNA vaccine as a novel cancer immunotherapy.

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4350343

Cargo recognition and trafficking in selective autophagy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4350343

Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4350343

Broad-spectrum anti-tumor and anti-metastatic DNA vaccine based on p62-encoding vector.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4350343

Trial watch: DNA vaccines for cancer therapy

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4350343

When autophagy meets cancer through p62/SQSTM1.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4350343

Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4350343

Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccines

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4350343

Canine mammary tumours, an overview

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4350343

Dog models of naturally occurring cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4350343

FDA guidance on prophylactic DNA vaccines: analysis and recommendations

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4350343

p62 at the crossroads of autophagy, apoptosis, and cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4350343

Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4350343

Translation of new cancer treatments from pet dogs to humans

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4350343

Survivin DNA vaccine generated specific antitumor effects in pancreatic carcinoma and lymphoma mouse models

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4350343

Non-oncogene addiction and the stress phenotype of cancer cells

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4350343

Signal integration and diversification through the p62 scaffold protein

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4350343

Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4350343

Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4350343

Prognostic relevance of altered Fas (CD95)-system in human breast cancer

27 September 2018

1 reference

12 December 2020

Influence of host factors on survival in dogs with malignant mammary gland tumors

1 reference

12 December 2020

Histological grading and prognosis in dogs with mammary carcinomas: application of a human grading method

1 reference

12 December 2020

Companion therapeutics

1 reference

12 December 2020

Adjuvant therapy for osteosarcoma in dogs: results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin

1 reference

12 December 2020

Identifiers

DOI

10.18632/ONCOTARGET.2516

0 references

PMC publication ID

4350343

1 reference

6 August 2017

1 reference